US Broker Ratings

Replimune Group, Inc. (REPL): Investor Outlook on This Biotech’s 52.88% Upside Potential

Replimune Group, Inc. (NASDAQ: REPL) is making waves in the biotechnology sector with its innovative approach to cancer treatment and significant upside potential. This clinical-stage company, headquartered in Woburn, Massachusetts,..

uniQure N.V. (QURE) Stock Analysis: Exploring a 120% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector may find uniQure N.V. (NASDAQ: QURE) an intriguing prospect, especially given its remarkable potential upside of 120.27%. Based in Amsterdam, Netherlands,..

Simulations Plus, Inc. (SLP)

⚠️ No article content returned.

..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: Exploring a 55% Potential Upside in Biotech

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biopharmaceutical sector, is capturing investor attention with its promising pipeline of cancer therapies. Headquartered in New York, this biotechnology firm..

CorMedix Inc. (CRMD) Stock Analysis: Exploring a Potential 106% Upside

For investors seeking opportunities in the biotechnology sector, CorMedix Inc. (CRMD) offers a compelling case. With a potential upside of 106.69%, the stock has garnered attention due to its promising..

Oculis Holding AG (OCS) Stock Analysis: A 76% Upside Potential Beckons in the Biotech Arena

Oculis Holding AG (OCS), a promising player in the biotechnology sector, is garnering attention, particularly for its groundbreaking work in ophthalmic and neuro-ophthalmic treatments. With its headquarters in Zug, Switzerland,..

Xeris Biopharma (XERS) Stock Analysis: Exploring an 84% Potential Upside

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its impressive potential upside of 84.48%, based on the current average analyst target price of $11.14. This..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 135% Potential Upside in the Healthcare Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical device company based in Irvine, California, Beta..

LENZ Therapeutics (LENZ) Stock Analysis: Exploring a 325% Upside Potential in Biotechnology

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biotechnology sector, is capturing investor interest with its innovative focus on vision-improving therapies and a remarkable potential upside. Headquartered in..

Weave Communications, Inc. (WEAV) Stock Analysis: Unveiling a 78% Potential Upside in the Health Information Sector

Weave Communications, Inc. (NASDAQ: WEAV) is carving out a substantial niche in the health information services industry, offering a robust AI-powered platform tailored for small to medium-sized healthcare businesses. With..

Nutex Health Inc. (NUTX) Investor Outlook: Analyzing 119.65% Potential Upside

For investors seeking opportunities within the healthcare sector, Nutex Health Inc. (NUTX) presents a compelling case, driven by its unique business model and intriguing market potential. With a market capitalization..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth and Valuation Challenges in the Healthcare Sector

In the dynamic landscape of the healthcare industry, STAAR Surgical Company (NASDAQ: STAA) stands out as a notable player within the medical instruments and supplies sector. With a market capitalization..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Exploring Growth Amidst a Challenging Landscape

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is capturing investor attention with its expansive reach..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 67.65% Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the healthcare sector specializing in drug manufacturing, presents a compelling opportunity for investors with its noteworthy upside potential. This Massachusetts-based pharmaceutical..

InMode Ltd. (INMD) Stock Analysis: Unveiling a 23% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), renowned for its pioneering advancements in minimally invasive aesthetic medical products, is capturing investor attention with its promising potential upside of 23.28%. Headquartered in Yokne’am, Israel,..

PAR Technology Corporation (PAR) Stock Analysis: A Deep Dive into 178% Potential Upside

With a storied history dating back to 1968, PAR Technology Corporation (NYSE: PAR) is a prominent player in the technology sector, specifically within the software application industry. Best known for..

SAP SE (SAP) Stock Analysis: Exploring a 69.33% Potential Upside with Analyst Consensus

SAP SE (SAP), a global leader in enterprise application software, stands out in the technology sector as a compelling option for investors seeking growth and stability. Headquartered in Walldorf, Germany,..

Datadog, Inc. (DDOG) Stock Analysis: Strong Buy Ratings and a 53% Upside Potential Captivate Investors

Datadog, Inc. (NASDAQ: DDOG), a prominent player in the technology sector, is capturing significant attention from investors, thanks to its robust growth metrics and favorable analyst ratings. With a market..

Q2 Holdings, Inc. (QTWO) Stock Analysis: Robust Growth Potential with a 61% Upside

Q2 Holdings, Inc. (NASDAQ: QTWO), a key player in the software application industry, is drawing considerable attention from investors with its potential for substantial upside. With a current market cap..

Zoom Communications, Inc. (ZM) Stock Analysis: Evaluating a Potential 20.61% Upside in the Tech Sector

Zoom Communications, Inc. (NASDAQ: ZM) has captivated the technology sector with its robust platform and innovative offerings. With a market capitalization of $23.9 billion, the company is a formidable player..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds